In the United States, doctors in the 50 to 70 age group often indicate low dose of aspirin daily, to prevent doctors and heart attacks, even if they do not have any associated diseases.
In Europe, cardiologists do the same after the first heart problem.
Aspirin makes the blood liquid and prevents clots from closing in the arteries. Some doctors say, but a very good blood can cause bleeding. So dilemma: What types of patients are exposed to the risk of hemorrhaging due to the reduction of cardiovascular risk?
For many people who have stroke or heart attack, it is balanced to take aspirin. These people have a clear risk of another accident, and aspirin helps prevent it.
A new study, published in the Journal of the American Medical Association (JAMA) on Tuesday, offers a warm perspective to patients who do not have cardiovascular problems yet.
But he does not really compromise the dispute: he says, on one hand, Aspirin reduces the risk of heart attack and stroke among people without history; But, on the other hand, it increases the risk of severe bleeding, especially in the brain, stomach and intestines.
Aspirin has no effect on mortality in one way or another.
Oxford University's Epidemiology Professor Jane Armamage said, "For the healthier people, aspirin losses in the prevention of stroke and cardiovascular attacks increase the risk of bleeding."
As a conclusion, doctors should recommend aspirin based on case-by-case basis on other risks of the patient, cardiologist Michael Gaziano wrote in the comment.
For example, There are other methods for reducing smoking or decreasing cardiovascular risk in lower levels of cholesterol levels.
This new study is Meta-Analysis, which means two authors of the King of College London studied the 13 most important clinical trials on subjects from 1988 to 2018, and concluded based on all these tests.
This method eliminates the uncertainty associated with each study, and generally recognizes the general impact based on 164,000 participants in the trial.
The surprise is that researchers have not found any link between aspirin and the number of cancers decreasedWhat more and more studies have shown is that aspirin reduces the risk of certain cancers, especially colorectal cancer.
The Executive Group of the Executive Services of the United States (US Preventive Services Task Force), an organization that provides public health recommendations, is among people aged 50 to 69 years aspirin for daily access to people. In other cases, this reduces the incidence of cancer.